• Profile
Close

Clinical impact of cachexia in head and neck cancer patients who received chemoradiotherapy

Cancer Management and Research Nov 11, 2021

Hayashi N, Sato Y, Fujiwara Y, et al. - Findings demonstrate a negative link between cancer cachexia and prognosis in patients with head and neck cancer (HNC) who underwent definitive chemoradiotherapy. In these cases, improvement in survival could be achieved through nutritional intervention during chemoradiotherapy.

  • This study involved 192 head and neck cancer patients, and clinical results were compared between cachexia and non-cachexia cases in definitive and adjuvant chemoradiotherapy settings.

  • Cachexia was present in 40 patients (20.8%).

  • The cachexia group had significantly shorter overall survival (OS) in the definitive setting (3-year OS: 50.0% vs 88.5%), and poor prognostic factors revealed in the multivariate analysis included UICC stage IV, baseline albumin of < 4 and cachexia.

  • However, cachexia lost significance in the adjuvant setting.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay